Metallocorroles as cytoprotective agents against oxidative and nitrative stress in cellular models of neurodegeneration

Journal of Neurochemistry

Volumn 113, Issue 2, 2010, Pages 363-373

  Kupershmidt, Lana ^a   Okun, Zoya ^a   Amit, Tamar ^a   Mandel, Silvia ^a   Saltsman, Irena ^a   Mahammed, Atif ^a   Bar Am, Orit ^a   Gross, Zeev ^a   Youdim, Moussa B H ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

6 OHDA; Metallocorroles; Neurodegenerative diseases; Neuroprotection; Oxidative nitrative stress; SIN 1

Indexed keywords

3 NITROTYROSINE; CASPASE 3; FERRIC ION CORROLE; HYDROGEN PEROXIDE; LINSIDOMINE; MANGANESE IRON CORROLE; NEUROMODULIN; NEUROPROTECTIVE AGENT; OXIDOPAMINE; PEROXYNITRITE; PORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MOTONEURON; MOUSE; NERVE DEGENERATION; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NITRATION; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; CASPASE 3; CELL COUNT; CELL DEATH; CELL LINE, TUMOR; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; HUMANS; HYDROGEN PEROXIDE; IN SITU NICK-END LABELING; METALLOPORPHYRINS; MICE; MOLSIDOMINE; MOTOR NEURONS; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; NITRATES; OXIDATIVE STRESS; OXIDOPAMINE; PORPHYRINS; SYMPATHOLYTICS;

EID: 77949767055     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06619.x     Document Type: Article

References (57)

1. Aviv I. Gross Z. (2007) Corrole-based applications. Chem. Commun. (Camb) 20, 1987 1999.
2. Aviv-Harel I. Gross Z. (2009) Aura of corroles. Chemistry - Eur. J. 15, 8382 8394.
3. Bar-Am O., Amit T. Youdim M. B. (2007) Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro. J. Neurochem. 103, 500 508.
4. Benov L. Batinic-Haberle I. (2005) A manganese porphyrin suppresses oxidative stress and extends the life span of streptozotocin-diabetic rats. Free Radic. Res. 39, 81 88.
5. Bruchelt G., Schraufstatter I. U., Niethammer D. Cochrane C. G. (1991) Ascorbic acid enhances the effects of 6-hydroxydopamine and H2O2 on iron-dependent DNA strand breaks and related processes in the neuroblastoma cell line SK-N-SH. Cancer Res. 51, 6066 6072.
6. Cashman N. R., Durham H. D., Blusztajn J. K., Oda K., Tabira T., Shaw I. T., Dahrouge S. Antel J. P. (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 194, 209 221.
7. von Coelln R., Kugler S., Bahr M., Weller M., Dichgans J. Schulz J. B. (2001) Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J. Neurochem. 77, 263 273.
8. Crow J. P. (1999) Manganese and iron porphyrins catalyze peroxynitrite decomposition and simultaneously increase nitration and oxidant yield: implications for their use as peroxynitrite scavengers in vivo. Arch. Biochem. Biophys. 371, 41 52.
9. Cuzzocrea S., Costantino G., Mazzon E., De Sarro A. Caputi A. P. (1999) Beneficial effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in zymosan-induced shock. Br. J. Pharmacol. 128, 1241 1251.
10. Davison A. J., Legault N. A. Steele D. W. (1986) Effect of 6-hydroxydopamine on polymerization of tubulin. Protection by superoxide dismutase, catalase, or anaerobic conditions. Biochem. Pharmacol. 35, 1411 1417.
11. Eckshtain M., Zilbermann I., Mahammed A., Saltsman I., Okun Z., Maimon E., Cohen H., Meyerstein D. Gross Z. (2009) Superoxide dismutase activity of corrole metal complexes. Dalton Trans. 38, 7879 7882.
12. Fahn S. Cohen G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804 812.
13. Feelisch M., Ostrowski J. Noack E. (1989) On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol. 14 (Suppl 11 S13 S22.
14. Gershman Z., Goldberg I. Gross Z. (2007) DNA binding and catalytic properties of positively charged corroles. Angew. Chem. Int. Ed. Engl. 46, 4320 4324.
15. Gilgun-Sherki Y., Melamed E. Offen D. (2001) Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40, 959 975.
16. Glinka Y., Gassen M. Youdim M. B. (1997) Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural Transm. Suppl. 50, 55 66.
17. Golden T. R. Patel M. (2009) Catalytic antioxidants and neurodegeneration. Antioxid. Redox Signal. 11, 555 570.
18. Goldstein S., Lind J. Merenyi G. (2005) Chemistry of peroxynitrites as compared to peroxynitrates. Chem. Rev. 105, 2457 2470.
19. Gorman A. M., McGowan A., O'Neill C. Cotter T. (1996) Oxidative stress and apoptosis in neurodegeneration. J. Neurol. Sci. 139 (Suppl 45 52.
20. Gross Z., Galili N. Saltsman I. (1999) The first direct synthesis of corroles from pyrrole. Angew. Chem. Int. Ed. 38, 1427 1429.
21. Groves J. T., Lee J. B. Marla S. S. (1997) Detection and characterization of an oxomanganese(V) porphyrin complex by rapid-mixing stopped-flow spectrophotometry. J. Am. Chem. Soc. 119, 6269 6273.
22. Haber A., Mahammed A., Fuhrman B., Volkova N., Coleman R., Hayek T., Aviram M. Gross Z. (2008) Amphiphilic/Bipolar metallocorroles that catalyze the decomposition of reactive oxygen and nitrogen species, rescue lipoproteins from oxidative damage, and attenuate atherosclerosis in mice. Angew. Chem. Int. Ed. Engl. 47, 7896 7900.
23. Jordan J., Galindo M. F., Tornero D., Gonzalez-Garcia C. Cena V. (2004) Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells. J. Neurochem. 89, 124 133.
24. Kupershmidt L., Amit T., Bar-Am O., Youdim M. B. Blumenfeld Z. (2007) The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases. J. Neurochem. 103, 962 971.
25. Kupershmidt L., Weinreb O., Amit T., Mandel S., Carri M. T. Youdim M. B. (2009) Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 23, 3766 3779.
26. Levites Y., Amit T., Youdim M. B. Mandel S. (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J. Biol. Chem. 277, 30574 30580.
27. Liang L. P., Huang J., Fulton R., Day B. J. Patel M. (2007) An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity in vivo. J. Neurosci. 27, 4326 4333.
28. Mabley J. G., Liaudet L., Pacher P., Southan G. J., Groves J. T., Salzman A. L. Szabo C. (2002) Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Mol. Med. 8, 581 590.
29. Mahammed A. Gross Z. (2005) Albumin-conjugated corrole metal complexes: extremely simple yet very efficient biomimetic oxidation systems. J. Am. Chem. Soc. 127, 2883 2887.
30. Mahammed A. Gross Z. (2006) Iron and manganese corroles are potent catalysts for the decomposition of peroxynitrite. Angew. Chem. Int. Ed. Engl. 45, 6544 6547.
31. Mahammed A., Goldberg I. Gross Z. (2001) Highly selective chlorosulfonation of tris(pentafluorophenyl)corrole as a synthetic tool for the preparation of amphiphilic corroles and metal complexes of planar chirality. Org. Lett. 3, 3443 3446.
32. Maji S., Kumar A., Pal K. Sarkar S. (2005) Reversible penta- and hexacoordination motifs in [Co(TMPP)] resulting in interchange of 1D and 2D supramolecular designs. Inorg. Chem. 44, 7277 7279.
33. Maruyama W., Takahashi T., Youdim M. Naoi M. (2002) The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells. J. Neural Transm. 109, 467 481.
34. Nie G., Cao Y. Zhao B. (2002) Protective effects of green tea polyphenols and their major component, (-)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells. Redox Rep. 7, 171 177.
35. Okun Z., Kupershmidt L., Amit T., Mandel S., Bar-Am O., Youdim M. B. Gross Z. (2009) Manganese corroles prevent intracellular nitration and subsequent death of insulin-producing cells. ACS Chem. Biol. 4, 910 914.
36. Olmos A., Giner R. M. Manez S. (2007) Drugs modulating the biological effects of peroxynitrite and related nitrogen species. Med. Res. Rev. 27, 1 64.
37. Pacher P., Beckman J. S. Liaudet L. (2007) Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315 424.
38. Paolesse R. (2000) Syntheses of Corroles, in Heteroporphyrins, expanded porphyrins and related macrocycles Kadish K., Smith K. Guilard R., eds), The Porphyrin Handbook. Vol. 2, pp. 201 301. Academic Press, NY.
39. Patel M. Day B. J. (1999) Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharmacol. Sci. 20, 359 364.
40. Perez M. J. Cederbaum A. I. (2002) Antioxidant and pro-oxidant effects of a manganese porphyrin complex against CYP2E1-dependent toxicity. Free Radic. Biol. Med. 33, 111 127.
41. Rabkin S. W. Klassen S. S. (2008) Metalloporphyrins as a therapeutic drug class against peroxynitrite in cardiovascular diseases involving ischemic reperfusion injury. Eur. J. Pharmacol. 586, 1 8.
42. Radovits T., Seres L., Gero D. et al. (2007) The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction. Mech. Ageing Dev. 128, 173 181.
43. Riley D. P. (1999) Functional mimics of superoxide dismutase enzymes as therapeutic agents. Chem. Rev. 99, 2573 2588.
44. Ross J. A. Kasum C. M. (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 22, 19 34.
45. Saltsman I., Mahammed A., Goldberg I., Tkachenko E., Botoshansky M. Gross Z. (2002) Selective substitution of corroles: nitration, hydroformylation, and chlorosulfonation. J. Am. Chem. Soc. 124, 7411 7420.
46. Saltsman I., Botoshansky M. Gross Z. (2008) Facile synthesis of ortho-pyridyl-substituted corroles and molecular structures of analogous porphyrins. Tetrahedron Lett. 49, 4163 4166.
47. Saner A. Thoenen H. (1971) Model experiments on the molecular mechanism of action of 6-hydroxydopamine. Mol. Pharmacol. 7, 147 154.
48. Sheng H., Enghild J. J., Bowler R. et al. (2002) Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic. Biol. Med. 33, 947 961.
49. Sheng H., Spasojevic I., Warner D. S. Batinic-Haberle I. (2004) Mouse spinal cord compression injury is ameliorated by intrathecal cationic manganese(III) porphyrin catalytic antioxidant therapy. Neurosci. Lett. 366, 220 225.
50. Shimizu E., Hashimoto K., Komatsu N. Iyo M. (2002) Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells. Neuropharmacology 43, 434 443.
51. Simonian N. A. Coyle J. T. (1996) Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36, 83 106.
52. Szabo C., Mabley J. G., Moeller S. M. et al. (2002) Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol. Med. 8, 571 580.
53. Szabo C., Ischiropoulos H. Radi R. (2007) Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6, 662 680.
54. Wang T., Liu B., Qin L., Wilson B. Hong J. S. (2004) Protective effect of the SOD/catalase mimetic MnTMPyP on inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuronal-glial cultures. J. Neuroimmunol. 147, 68 72.
55. Weinreb O., Bar-Am O., Amit T., Chillag-Talmor O. Youdim M. B. (2004) Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members. FASEB J. 18, 1471 1473.
56. Wu A. S., Kiaei M., Aguirre N., Crow J. P., Calingasan N. Y., Browne S. E. Beal M. F. (2003) Iron porphyrin treatment extends survival in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurochem. 85, 142 150.
57. Zhao Y., Chaiswing L., Oberley T. D., Batinic-Haberle I., St Clair W., Epstein C. J. St Clair D. (2005) A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. Cancer Res. 65, 1401 1405.